AIRT reports higher first-quarter fiscal 2026 revenue, driven by strong Ground Support Equipment gains despite a deeper loss.

Elite Pharmaceuticals reports strong first-quarter fiscal 2026 results with rising direct sales, higher-margin products and expanding gross profit.

Elite Pharmaceuticals reports strong first-quarter fiscal 2026 results with rising direct sales, higher-margin products and expanding gross profit.

SJM's first-quarter earnings and sales miss estimates as volume declines, with it updating the fiscal 2026 outlook.

SJM's first-quarter earnings and sales miss estimates as volume declines, with it updating the fiscal 2026 outlook.

RVP reports stronger second-quarter 2025 sales and narrows losses as domestic output offsets tariff headwinds.

RVP reports stronger second-quarter 2025 sales and narrows losses as domestic output offsets tariff headwinds.

SIF returns to profitability in third-quarter fiscal 2025 as strong aerospace demand and cost cuts lifted margins and earnings.

SIF returns to profitability in third-quarter fiscal 2025 as strong aerospace demand and cost cuts lifted margins and earnings.

KSS tops earnings and revenue estimates in Q2 2025 despite sales declines, with margins and operating income showing strong gains.